Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
O15:FRA
Insilico Medicine Cayman TopCo
€7.55
-1.95%
(-0.15) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for O15...
Open
€7.55
High
€7.85
Low
€7.50
Mkt. cap
40.50B
Avg. vol.
606.00
Volume
151.00
52-wk high
€9.00
52-wk low
€5.35
No. of employees
317
News stories
From sources across the web
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees317
Founded2014
Headquarters-
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.73M
13.73M
14.39M
14.39M
Cost of goods sold
2.22M
2.22M
2.98M
2.98M
Cost of revenue
2.22M
2.22M
2.98M
2.98M
Research and development expenses
17.79M
17.79M
22.90M
22.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.82M
4.82M
7.05M
7.05M
Operating expense
22.69M
22.69M
30.23M
30.23M
Total operating expenses
24.91M
24.91M
33.20M
33.20M
Operating income
-11.18M
-11.18M
-18.81M
-18.81M
Other non operating income
-1.19M
-1.19M
-149.82M
-149.82M
EBT including unusual items
-9.59M
-9.59M
-166.54M
-166.54M
EBT excluding unusual items
-10.85M
-10.85M
-167.61M
-167.61M
Income tax expense
20.50K
20.50K
9.50K
9.50K
Effective tax rate
-0.21%
-0.21%
-0.01%
-0.01%
Other operating expenses
-
-
-
-
Net income
-9.61M
-9.61M
-166.55M
-166.55M
Net profit margin
-69.98%
-69.98%
-1,157.28%
-1,157.28%
Earnings per share
-
-
-
-
Interest and investment income
1.48M
1.48M
1.29M
1.29M
Interest expense
-48.50K
-48.50K
-56.00K
-56.00K
Net interest expenses
1.43M
1.43M
1.24M
1.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.57M
-10.57M
-18.20M
-17.70M
Gain or loss from assets sale
500.00
500.00
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more